期刊文献+

背驮式原位肝移植术四例报告 被引量:6

Piggyback orthotopic liver transplantation of 4 cases
原文传递
导出
摘要 目的为了提高终末期肝病的存活率。方法于1996年5月、8月、1997年1月和1998年2月先后成功地施行了4例背驮式原位肝移植术(包括1例减体积性肝移植术)。结果除例1乙型肝炎后肝硬变,受体术后214天突然死于乙肝复发并急性肝坏死和急性胰腺炎外,例2、例3和例4肝豆状核变性受体术后恢复顺利,效果良好,已分别健康生存575天、390天和162天。 Objective To increase the survival rate of end stage liver diseases. Methods The piggyback orthotopic liver transplantation was successfully performed in 4 cases from May 1996 to Feb. 1998 in our hospital.Among the 4 cases, one received operation of reduced size piggyback orthotopic liver transplantation. Results Except one case of the cirrhosis caused by the hepatitis B died from the recurrence of hepatitis B with acute hepatic necrosis and acute pancreatitis, 3 cases of Wilson disease recovered smoothly with satisfactory results post transplantation. They have healthily survived 575 days, 390 days and 162 days, respectively. Conclusion Liver/transplantation is the best effective treatment for the most end stage liver diseases at present.
出处 《中华器官移植杂志》 CAS CSCD 1999年第2期68-70,共3页 Chinese Journal of Organ Transplantation
关键词 肝移植 肝豆状核变性 病例报告 Liver/transplantation Wilson disease
  • 相关文献

参考文献4

  • 1杨甲梅,马立业,陈汉,吴孟超,肖飞.供体肝切取方法及其选择[J].中华器官移植杂志,1995,16(1):15-17. 被引量:15
  • 2吴孟超 张晓华 等.同种原位肝移植术(附3例报告)[J].中华器官移植杂志,1984,5:121-123.
  • 3杨甲梅,中华器官移植杂志,1995年,16卷,15页
  • 4吴孟超,中华器官移植杂志,1984年,5卷,121页

共引文献14

同被引文献43

  • 1彭淑牖,江献川,李君达,蔡秀军,彭承宏,苏英.刮吸法断肝术临床应用报告[J].实用外科杂志,1993,13(1):17-19. 被引量:112
  • 2杨甲梅,马立业,陈汉,吴孟超,肖飞.供体肝切取方法及其选择[J].中华器官移植杂志,1995,16(1):15-17. 被引量:15
  • 3Robert P , Jorge R , J ules D , et al. Molticenter study of lamivudine therapy for hepatitis B after liver transplantation[J]. Hepatology, 1999,29: 158121586.
  • 4Tzakis AG, Todos, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava[J]. Ann Surg, 1989,210:649
  • 5Scatton O, Meunier B, Cherqui D , et al. Randomized trail of cholechodochostomy with or without a t tube in orthotopic liver transplantation [ J ].Ann Surg,2001,233(3) :432
  • 6Wiesener RN. A long-term comparison of tacrolimus(FK506)versus cyclosporine in liver transplantation: AreportoftheUnitedStatesFK506StudyGroup [J]. Transplantation, 1998,66:493.
  • 7Eckhoff DE , McGuire B , Sellers M , et al. The safety and efficacyof a two2dose daclizumab (zenapax) induction therapy in liver transplant recipients[J] .Transpl,2000,69:186721872.
  • 8Niemeyer G, Koch M , Light S , et al. Long2term safety , tolerability and efficacy of daclizumab (zanapax) in a two2dose regimen in liver transplant recipients[J]. Am Transpl, 2002,2:4542460.
  • 9McDiarmid SV,Busuttil RW,Ascher NL,et al.FK506(tacrolimus) comp ared with cyclosprine for primary immunosuppression after pediatric liver transp lantation: Results from the U.S.Multicenter Trial[J].Transplantation,1995,59(4): 530-536.
  • 10Starzl TE,KOEP LJ,Weill RⅢ,et al .Development of a suprahepatic recipient vena cava cuff for liver transplantati on[J].SGO,1979,149: 76.

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部